CIK: 0001232621 · Show all filings
Period: Q1 2014 (← Previous) (Next →)
Filing Date: May 15, 2014
Total Value ($000): $206,207 (71.3% shares, 28.7% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS INC | 4,408,987 | $61,329 | 29.7% | $12.60 | 0.0% | COM | 427746102 |
| — | PDL BIOPHARMA INC | 25,974,000 | $40,197 | 19.5% | $1.41 | — | NOTE 2.875% 2/15/15 | 69329YAE4 |
| — | SALIX PHARMACEUTICALS INC | 300,000 | $31,083 | 15.1% | $66.15 | — | COM | 795435106 |
| — | OPKO HEALTH INC | 14,000,000 | $19,040 | 9.2% | $1.04 | — | NOTE 3.0% 2/1/33 | 68375NAA1 |
| — | HORIZON PHARMA INC | 1,000,000 | $15,120 | 7.3% | $15.12 | — | COM | 44047T109 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 182,300 | $12,435 | 6.0% | $62.32 | +18.3% | COM | 09061G101 |
| — | ENDOCYTE INC | 465,763 | $11,090 | 5.4% | $13.13 | — | COM | 29269A102 |
| — | MIRATI THERAPEUTICS INC | 435,843 | $8,312 | 4.0% | $15.15 | — | COM | 60468T105 |
| — | MANNKIND CORP | 1,800,000 | $7,236 | 3.5% | $4.72 | — | COM | 56400P201 |
| — | DENDREON CORP | 55,548 | $166 | 0.1% | $4.12 | — | COM | 24823Q107 |
| — | LA JOLLA PHARMACEUTICAL CO | 11,219 | $121 | 0.1% | $10.79 | — | COM | 503459604 |
| — | RXI PHARMACEUTICALS CORP | 18,245 | $78 | 0.0% | $4.28 | — | COM | 74979C303 |
| — | AMBIT BIOSCIENCES CORP | 46 | $0 | 0.0% | — | — | COM | 02318X100 |